Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
pimecrolimus peptidyl-prolyl cis-trans isomerase fkbp1a small molecule NA drugbank , DGIDB Eczema[MeSHID:D004485]
Dermatitis
Atopic[MeSHID:D003876]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 4.55 approved,investigational potentiator,inhibitor
pimecrolimus peptidyl-prolyl cis-trans isomerase fkbp1a small molecule NA drugbank , DGIDB Eczema[MeSHID:D004485]
Dermatitis
Atopic[MeSHID:D003876]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 4.55 approved,investigational potentiator
pimecrolimus serine/threonine-protein kinase mtor small molecule NA drugbank , DGIDB Eczema[MeSHID:D004485]
Dermatitis
Atopic[MeSHID:D003876]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.32 approved,investigational potentiator
pimecrolimus calcineurin NA Successful target TTD , DGIDB Eczema[MeSHID:D004485]
Dermatitis
Atopic[MeSHID:D003876]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 5.3 approved unknown
click here to return to the previous page